From earlier this week: This first-in-disease study supports the use of GLP-1 agonist in pulmonary vascular disease
Colm McCabe & team show the GLP-1 agonist exenatide causes acute relaxation of lung blood vessels in pulmonary arterial hypertension: doi.org/10.1172/jci....
